Diabetes mellitus type 2 drives metabolic reprogramming to promote pancreatic cancer growth

BACKGROUND: Diabetes mellitus type 2 (DM2) is a modifiable risk factor associated with pancreatic carcinogenesis and tumor progression on the basis of epidemiology studies, but the biological mechanisms are not completely understood. The purpose of this study is to demonstrate direct evidence for th...

Descripción completa

Detalles Bibliográficos
Autores principales: Velazquez-Torres, Guermarie, Fuentes-Mattei, Enrique, Choi, Hyun Ho, Yeung, Sai-Ching J, Meng, Xiangqi, Lee, Mong-Hong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2020
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434590/
https://www.ncbi.nlm.nih.gov/pubmed/32843973
http://dx.doi.org/10.1093/gastro/goaa018

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7434590/
https://www.ncbi.nlm.nih.gov/pubmed/32843973
http://dx.doi.org/10.1093/gastro/goaa018

Ejemplares similares